Articles by: Geisel Communications

In Good Health: The Latest on Vaping Regulations (Audio) – 1a

Listen here – Mitch Zeller, senior associate dean of clinical and translational research, is featured on an episode of In Good Health to discuss vaping regulations. “You can’t just abolish two entire offices in a center that is ordered by Congress to regulate the single most harmful, deadly, and dangerous consumer product and expect there not to be public health ramifications,” Zeller said. (Zeller’s comments begin at approximately 5:30.)

Dartmouth Medical Student Warns the Public That Popular Household Appliances Contain Carcinogens: ‘It’s Important That People Know the Health Effects’ – The Cool Down

Read article – Alex Conway ’20, MED ’25, is featured in an article about a video she posted related to the health effects of methane emissions from gas stove tops.”I think it’s important that people know about the health effects of methane gas because it’s something we can change,” Conway said.

Psychologists Are Calling for Guardrails Around AI Use for Young People. Here’s What to Watch Out For – CNET

Read article – Nicholas Jacobson, an associate professor of biomedical data science and psychiatry, is quoted in a story about an American Psychological Association health advisory on AI and adolescents. “This is a new technology that is probably potentially as big in terms of its impact on human development as the internet,” Jacobson said.

ChatGPT Is Making Us Weird – Business Insider

Read article – Nicholas Jacobson, an associate professor of biomedical data science and psychiatry, talks about the risks of commercial therapy chatbots in the context of Therabot, the first AI therapy chatbot to undergo a clinical trial. “A lot of folks in Silicon Valley want to move fast and break things, but in this case, they’re not breaking things—they’re breaking people,” Jacobson said.

What to Know About Plasma Exchange Therapy and Longevity – The New York Times

Read article – Zbigniew M. Szczepiorkowski, a professor of pathology and laboratory medicine, is cited as a third-party expert in an article about the first trials on plasma exchange for anti-aging in humans. Szczepiorkowski notes that it’s not clear if the findings were a direct result of the treatment or if they were influenced by some other confounding factor.